Our sponsors

We are incredibly grateful for the generosity of our sponsors for Drug Repurposing for Rare Diseases 2022.

Headline

LifeArc is a self-funded medical research charity. Our mission is to advance translation of early science into health care treatments or diagnostics that can be taken through to full development and made available to patients. We have been doing this for more than 25 years and our work has resulted in a diagnostic for antibiotic resistance and four licensed medicines. 

Our success allows us to explore new approaches to stimulate and fund translation. We have our own drug discovery and diagnostics development facilities, supported by experts in technology transfer and intellectual property who also provide services to other organisations. Our model is built on collaboration, and we partner with a broad range of groups including medical research charities, research organisations, industry and academic scientists. We are motivated by patient need and scientific opportunity. 

LifeArc has a number of different funding mechanisms to invest in promising innovation for the benefit of patients. Our Philanthropic Fund provides grants to support medical research projects focused on the translation of rare diseases research.  Our Early Ventures investment strategy builds on our Seed Fund portfolio of start-up companies; investing in innovative new modalities, technologies and translational research that have the potential to generate impact for patients and income that will enable us to drive further innovation.  

Gold Corporate Partner

Deployed globally and focused on rare diseases, Pulse Infoframe is a real-world evidence (RWE) generation, health informatics and analytics company that has created a technology and services platform designed to extract, curate, analyze and disseminate evidence-based conclusions for the purpose of accelerating research, advancing therapeutic treatment options and improving the quality of life of patients.

Pulse Infoframe provides a full solution for registries, natural history studies and a range of other observational and regulatory-grade studies. The company designs, implements and launches global registries, with dynamic patient consent models, FDA level data standardization (required for global studies and analytics) and data compliance.

Pulse Infoframe has relationships with key opinion leaders, providers and industry. Using its in-house expertise and experience, the company addresses their requirements throughout the product development continuum from research to market access.

www.pulseinfoframe.com

Gold Sponsor

Aparito logo

Evolution Education Trust provides grants to research and charitable organisations founded on the scientific principles of evolution and advances in genetics.

Bronze

Sponsorship opportunities

 Our conference is essential in breaking down barriers between patients, industry, healthcare professionals and researchers.

COVID-19 has starved us of opportunities for interaction, but the cross-sector audience and relaxed atmosphere of Beacon’s events fosters collaboration and inspiration at a time when it is most needed.

By partnering with Drug Repurposing for Rare Diseases 2022, you will be providing an opportunity for all members of the rare disease community to meet – in person – and share ideas, making a life changing difference to the millions of patients and families living with rare diseases.

We have a range of partnership packages suitable for every budget, which include opportunities to speak, exhibit, advertise and more. Get in touch with sophia@rarebeacon.org to discuss your options.